tiprankstipranks
Trending News
More News >

ImmunoGen downgraded to Equal Weight from Overweight at Barclays

Barclays downgraded ImmunoGen (IMGN) to Equal Weight from Overweight after the company agreed to be acquired by AbbVie (ABBV) for $31.26 per share in cash.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on IMGN:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue